LENZ Therapeutics LENZ
NASDAQ LENZ
$3.22 +0.03 (+0.94%)
As of: Oct 21, 2026 · 3:59 PM EDT

LENZ Therapeutics (LENZ) Restructuring Costs (2023)

Updated

LENZ Therapeutics (LENZ) reported Restructuring Costs of $10.95 million for Q4 2023, down 3.5% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Restructuring Costs (2023) Analysis & Trends

For FY2023, LENZ Therapeutics posted Restructuring Costs of $62.08 million.

  • Five-year quarterly Restructuring Costs spans a low of $2.58 million in Q1 2023 and a high of $37.2 million in Q2 2023.
  • Per Business Quant data, the three quarters before Q4 2023 came in at $11.35 million (Q3 2023), $37.2 million (Q2 2023) and $2.58 million (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 LENZ Therapeutics 101.65 Mn -871.25 Mn 5.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 10.95 Mn
Sep 30, 2023 11.35 Mn
Jun 30, 2023 37.20 Mn
Mar 31, 2023 2.58 Mn
API Access

LENZ Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=LENZ&period=max&api_key=YOUR_API_KEY